News

March 30, 2015March 30, 2015

Cipher Pharmaceuticals Acquires Canadian Rights To New Rheumatoid Arthritis Treatment

Cipher Pharmaceuticals Inc. recently announced that the company has secured the license to distribute CF101 in Canada. CF101 is a new chemical being advanced by Can-Fite Biopharma to address rheumatoid arthritis and moderate to severe plaque ... Read more

March 27, 2015March 27, 2015

World Trade Center NY Residents and Rescue/Recovery Workers are More Susceptible to Autoimmune Diseases

News

A recent study published in the journal Arthritis & Rheumatology revealed that rescue and recovery workers involved in the events involving the World Trade Center (WTC) terrorist attack in 2001 in ... Read more

March 26, 2015March 26, 2015

Data on Purdues’ Reformulated OxyContin® for Chronic Pain Shows Decrease in Toxic, Addictive Effects

News, rheumatoid arthritis

Purdue Pharma, a privately-held pharmaceutical company that conducts research on chronic pain conditions such as Rheumatoid Arthritis, recently announced results of follow-up data showing a reduction in opioid poisoning, abuse ... Read more

March 25, 2015March 25, 2015

Digital X-Ray Radiogrammetry to Evaluate Bone Mineral Density in Rheumatoid Arthritis Patients

News, rheumatoid arthritis

A study recently published in the journal Arthritis showed that digital X-ray radiogrammetry can be used as an imaging tool to assess bone mineral density loss in patients with rheumatoid ... Read more

March 24, 2015March 25, 2015

Researchers Explore Effect of Prednisone For Rheumatoid Arthritis Biologics Treatments

News, rheumatoid arthritis

Results from a recent study indicate that an IFN-score based model to predict the clinical outcome of rituximab treatment can be optimized with the employment of prednisone use. The study ... Read more

March 23, 2015March 26, 2015

Longitudinal Study Finds That Vitamin D in Early Rheumatoid Arthritis Reduces Disease Activity

News, rheumatoid arthritis

Findings from a recent longitudinal study published in the journal BMC Musculoskeletal Disorders revealed treatment with vitamin D reduces disease activity in patients with early Rheumatoid Arthritis and basal hypovitaminosis ... Read more

March 20, 2015March 20, 2015

Study Suggests that Rheumatoid Arthritis Patients in Remission Can Safely Discontinue Treatment

News, rheumatoid arthritis

A collaborative study involving several hospitals and universities in Germany recently revealed that patients with rheumatoid arthritis in sustained remission can safely discontinue the treatment with disease-modifying anti-rheumatic drugs (DMARDs). ... Read more

March 19, 2015March 19, 2015

Samsung Bioepis Announces MAA Submission for SB2, Biosimilar Of Remicade

News

Samsung Bioepis Co., Ltd., has recently announced its submission to the European Medicines Agency (EMA) concerning the Marketing Authorization Application (MAA) for SB2, a biosimilar candidate for Remicade (Infliximab). This is the second MAA for biosimilar candidates that Samsung ... Read more

March 18, 2015March 18, 2015

Survivin Protein as a Potential Biomarker for Rheumatoid Arthritis

News

A new study published in the journal Medicine showed that the survivin protein could potentially be used as a diagnostic tool for rheumatoid arthritis (RA). The study is entitled “Recognizing ... Read more

March 17, 2015March 17, 2015

Evidence of Periodontitis in Rheumatoid Arthritis Patients

News, rheumatoid arthritis

The 93rd General Session and Exhibition of the International Association for Dental Research (IADR) was recently held in Boston, Massachusetts, between 11 and 14 of March, simultaneously with the 44th Annual ... Read more